COVID 19 and Cancer Services? Litigation Hotspot
By Dr Stephen Falk, Consultant Oncologist
Posted 02 June 2021
4 Minute Read
Tags:
- Cancer Diagnosis Delay
- Oncology Litigation
- COVID-19 Treatment Disruption
- Lung Cancer Referrals
- Oncologist Expert Witness
- Oncology Claims
Expert Disciplines:
- Oncology
About The Author
.jpg&w=384&q=75)
Dr Stephen Falk
Consultant Oncologist
Dr Stephen Falk is a Consultant Oncologist with extensive experience in medico-legal reporting. He qualified from Liverpool University in 1983 and completed oncology training in Cardiff and Cambridge before his consultant appointment in Bristol in 1994. He also holds sessional commitments at Southmead Hospital, Bristol. His specialist interests include gastrointestinal cancers (oesophagus, stomach, pancreas, colorectal, hepatobiliary), lung cancer, lymphomas, skin cancers, radiotherapy, and chemotherapy. Dr Falk is an experienced expert witness.
From the Blog
Related Articles
Gain crucial insight into COVID-related cancer service delays, their impact on diagnosis and treatment, and rising litigation risks - essential knowledge for clinical negligence practitioners.
Understand the pitfalls of delayed melanoma diagnosis and why relying solely on guidelines may fall short - vital insight for assessing breach, causation, and backwards extrapolation challenges.
Gain expert insight into ovarian cancer diagnosis, management, and legal challenges to help build stronger clinical negligence cases involving delayed diagnosis or surgical complications.
Thank you for your request!
We will get back to you as soon as possible.